Overview

Efficacy of Ivermectin and Albendazole Against Onchocerciasis in the Volta Region, Ghana

Status:
Completed
Trial end date:
2018-06-25
Target enrollment:
Participant gender:
Summary
We will examine whether a combination of Ivermectim (IVM) plus Albendazole (ALB) compared to IVM alone given annually, which is the current standard for mass drug administration (MDA), is more effective in sterilizing adult worms. We will also address whether IVM plus ALB given twice per year is superior to IVM given once per year or twice per year.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospitals Cleveland Medical Center
Treatments:
Albendazole
Ivermectin